Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease.
Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin?
Sources of information and behavioral patterns in online health forums: qualitative study.
Validity and reliability of the Greek version of the Modified Fatigue Impact Scale in multiple sclerosis patients.
Selection and optimization of therapy for progressive type multiple sclerosis.
Neuroimmunological diseases and pregnancy.
Oligodendrogenesis from neural stem cells: Perspectives for remyelinating strategies.
The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells.
STAT3 Activates miR-155 in Th17 cells and Acts in Concert to Promote Experimental Autoimmune Uveitis.
Gender differences in circulating levels of neutrophil extracellular traps in serum of multiple sclerosis patients.
Central nervous system B-cell lymphoma in multiple sclerosis.
Interferon-γ Activates Nuclear Factor-κ B in Oligodendrocytes through a Process Mediated by the Unfolded Protein Response.
Patients' perspectives on quality of mental health care for people with MS.
Short-term evolution of spinal cord damage in multiple sclerosis: a diffusion tensor MRI study.
Leuprolide Acetate, a GnRH Agonist, Improves Experimental Autoimmune Encephalomyelitis: A Possible Therapy for Multiple Sclerosis.
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.
Ischemic Preconditioning in White Matter: Magnitude and Mechanism.
Treatment of Neuromyelitis Optica: Review and Recommendations.
Parent-of-Origin Effects Implicate Epigenetic Regulation of Experimental Autoimmune Encephalomyelitis and Identify Imprinted Dlk1 as a Novel Risk Gene.
Disease activity and disability evolution under glatiramer acetate: A clinical approach.
Self-rating makes the difference: Identifying palliative care needs of patients feeling severely affected by multiple sclerosis.
Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes.
Bipolar disorder and multiple sclerosis: A case series.
New data presented at 29th ECTRIMS congress reinforce the clinical profile of investigational laquinimod on disease progression and inflammation in relapsing-remitting multiple sclerosis
Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis.
Pages
« first
‹ previous
…
345
346
347
348
349
350
351
352
353
…
next ›
last »